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Liver and Kidney Transplantation From Non-Heart Beating Donors: 
The Pittsburgh Experience 
A. Casavilla, C. Ramirez, R. Shapiro, D. Nghiem, K. Miracle, J.J. Fung, and T.E. Starzl 
NINETEEN liver and 51 kidney retrievals (one pediat-
ric pair is considered as a smgle organ) were per-
formed in 26 non-heart-beating donors (NHBD) over a 
5.5-year period. Consent for liver procurement was not 
obtained in seven cases. Fifty-seven allografts (14 livers and 
43 kidneys) were transplanted while the remainder (5 livers 
and 8 kidneys) were discarded because of macroscopic 
and/or microscopic findings. This report discusses the out-
come in this series of liver and kidney allografts from 
NHBD. 
MATERIALS AND METHODS 
Donors were divided into two groups: group 1 or uncontrolled 
NHBD (UNHBD: n == 14) included patients whose organs were 
recovered following a period of unsuccessful cardiopulmonary 
resuscitation (CPR: mean CPR time to pertusion 37 ::: 29 minutes. 
range to to lOO): and group 2 or controlled NHBD (CNHBD; n = 
12) included patients who died after choosing to forgo life-
sustaining treatment and developed cardiopulmonary arrest after 
extubation in an operating room setting (mean time from extuba-
tion to in situ perfusion 23.5 :!:: 9 minutes. range to to 42). 
Thirteen of 14 donors in the UNHBD group and 8 of 12 donors 
in the CNHBD group were male. The causes of death in the 
UNHBD/CNHBD groups were related to trauma (04%/33%). 
anoxic injury (28%/17%), and subarachnoid hemorrhage (8%/ 
42%): a remaining patient (8%) in the CNHBD group had a brain 
tumor. 
The mean prearrest serum creatinine. bilirubin. and aspartate 
transaminas.: (AST) for the UNHBD/CNHBD groups were 1.1 ::: 
0.5 (rang.: 0.6 to 3.2)10.8 ::: 0.2 (range U.5 to 1.2) mg/dL. U.6 ::: 0.4 
(range U.2 to 1.6)10.9 =: U.3 (range U.2 to I.S) mg/dL. and 164.8 ::: 
140.7 (range 37 to 469)/79.3 :!:: 62 (range 13 to 251) IL I. 
respectively. With one exception in each group. all donors requIred 
vasopressors. The mean dopamine dose at the time of laparotomy 
for the UNHBD and CNHBD groups was 10.9 ::: 12.2 (range () to 
40) and 11 :!:: 11.5 (range 0 to 35) Ilgfkgfmin. respectively. Most had 
good urine output prior to procurement (222 [range 0 to 10001 
mUh for group 1 and 231 [range 75 to 650] muh for group 2). 
The logistics and technique of NHBD procurement have been 
reported before. I In both groups. 30.000 U of heparin was admin-
istered prior to laparotomy. The essence of this "super rapid" 
retrieval technique entails a rapid cooling of the organs prior to any 
dissection by means of immediate cannulation and perfusion 
through the distal aorta and inferior mesenteric veins. A subse-
quent hepatectomy followed by en bloc nephrectomies is per-
formed as expeditiously as possible. The demographics of the 
kidney and liver recipients are shown in Table 1. 
RESULTS 
Of the 22 transplanted kidneys from UNHBD. 14 (63.6%) 
developed acute tubular necrosis (ATN), which lasted a 
mean of 14.2 ::!: 12.7 days (range 4-39), and 8 patients 
(36%) required hemodialysis posttransplant. Twenty pa-
tients (95%) were off dialysis by the time of discharge. Two 
grafts failed from arterial thrombosis and accelerated re-
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Table 1. Demographics for Kidney and Liver Recipients 
Kidney patients 
Mean age (y) 
Sex (M/F) 
Retransplants 
CIT (h) 
PRA 
-·40% 
,040% 
AntIgen match 
Antigen mIsmatch 
liver patIents 
Mean Age (y) 
Sex (F/M) 
UNOS score (US) 
EBL (U or PRBC) 
CIT (h) 
Crossmatch 
Gl 
22 
41.3 :: 16.0 (range 18-64) 
12/10 
2(9)% 
28.5:: 5.8 (range 14-39) 
3 (14%) 
19(86%) 
2.0 :: 1.2 (range 0-5) 
3.5 :: 1.0 (range 1-5) 
6 
39.7 :: 20.8 (range 0.4 -57) 
4/2 
US 4 = 3 patIents; US 3 ~ 3 patients 
10.5 :: 96 (range 1-27) 
10.6:!: 2.8 (range 9-16) 
All negatIve 
G2 
21 
46.2:: 12.9 (range 18-71) 
13/8 
2 (12%) 
25.4 ::: 8.3 (range 11-37) 
3 (14%) 
18 (86%) 
2.7 ::: 1.6 (range 0-6) 
2.7 ::: 1.5 (range 0-6) 
8 
47.2::: 18.9 (range 15-66) 
4/4 
US 3 = 7 patients; US 4 = 1 patient 
18.3 ::: 12 (range 0-34) 
11.0 ::: 2.5 (range 8-15) 
All negative 
AbbreViations: CIT. COld IschemiC time: PRA. panel reaCtive antlllOdy; EBl. estimated blood lOSS; PABC. packed red blood cells. 
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Fig 1. Kidney transplanta-
tion utilizing allografts from 
Non-Heart Beating Donors 
(January 1989 to July 1994). 
jection at 0.5 months and 2 months. respectively. Five 
patients died, three of whom had functioning kidneys, from 
respiratory failure. central nervous system (CNS) lym-
phoma, and sepsis (n = 3) between I to 38 months 
posttransplant. With a mean follow-up of 35 :: 21.4 months 
(range 14 to 60). 16 kidneys (73%) are still functioning with 
a mean serum creatinine of 1.7 :: 0.6 mgldL. The I-year 
actuarial patient and graft survival rates were 95% and 
Io:f,'c. respectively (Fig I). 
Of the 21 transplanted kidneys from CNHBD, 16 
:76.2%) experienced ATN. which lasted a mean of 8.9:: 8.8 
Jays (range 3 to 30), and 9 patients (43%) required 
hemodialysis posttransplant. All patients were off dialysis at 
the time of discharge. The most recent creatinine level is 
2.5 :: 1.3 mgldL at 16.5 :: 15.4 months follow-up (range 
I to 56). One patient with a functioning kidney died at 1.5 
months from a pulmonary embolus. Four grafts failed 
from histologically demonstrated chronic rejection be-
tween 5 and 38 months posttransplant. The I-year actu-
arial patient and graft survival rates were 94% and 79%, 
respectively (Fig 1). 
Of the six transplanted livers procured from UNHBD, 
three (50%) functioned with a peak serum bilirubin of 4.2 ::': 
11.4 mg/dL and a peak AST of 1135 :: 954.6 lUlL during the 
tiN week posttransplant. Two of these three patients 
. -,' uired retransplant at ion due to hepatic artery thrombosis 
I H.-H) and cytomegalovirus (CMV) hepatitis at 1.4 and 1.0 
months posttransplantation. respectively. One patient with 
a functioning liver is alive and well at 58 months posttrans-
plant. The remaining three patients required retransplan-
tat ian within the first week postoperatively because of 
primary nonfunction (PNF; n = 2) and inadequate portal 
flow (n = 1). The I-year actuarial patient and graft survival 
rates were 67% and 17%, respectively (Fig 2). 
Of the eight transplanted livers that were procured from 
CNHBD, all (100% ) functioned with a peak serum bilirubin 
of 10.5 ::': 9.3 mgldL and a peak AST of 744.6 :!: 483 lUlL 
within the first week posttransplantation. Two patients. 
both of whom died. required retransplantation at 0.9 and 
1.0 months due to HAT. One patient with a functioning 
liver died of a myocardial infarction at 2 months posttrans-
plantation. The remaining five patients are alive and well 
between 1 and 26 months follow-up. The I-year actuarial 
patient and graft survival rates were 50% and 50%, respec-
tively (Fig 2). 
DISCUSSION 
The last decade has witnessed the development of trans-
plantation as the treatment of choice for many patients with 
end-stage organ failure. Thousands of patients who would 
have otherwise died have been saved by the improved 
results of organ transplantation. However. this success has 
also exacerbated the problem of an insufficient number of 
donor organs. The 1993 annual report of the US Scientific 
Registry of Transplant Recipients and the Organ Procure-
ment and Transplantation Network2 highlights how acute 
this shortage of suitable allografts has become. During the 
period from 1988 to 1991. the number of patients awaiting 
transplantation has increased by 54%. During the same 
period of time, the number of pancreas, liver. heart. and 
kidney registrants who died while waiting for transplants 
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Fig 2. liver transplantation uti-
lizing allografts from Non-Heart 
Beating Donors (January 1989 
to July 1994). ·One patient with 
functioning liver died of a myo-
cardial infarction at 2 months 
posttransplant. 
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increased by 517%. 128%, 58%. and 35%. respectively. In 
contrast. the number of organ donors during the same 
period increased by only 15.5%. 
Although the need to expand the organ pool is great, 
these attempts at using NHBD are reasonable only if good 
quality grafts are obtained. We analyzed our experience 
with NHBD by dividing them into two categories. The first 
group consisted of UNHBD. Although 64% of the kidneys 
from uncontrolled NHBD experienced ATN. the overall 
I-year patient and graft survival rates in this group was 
excellent at 95% and 86%. The quality of these grafts has 
heen sustained over time and with a mean follow-up of 35 
months and 73% of these grafts are still functioning. The 
experience with livers procured from this group of patients 
was not as satisfactory; 33.3% of the organs transplanted 
from this group of donors experienced PNF (two of six), 
one liver with inadequate portal inflow failed within a week 
posttransplant (technically related). and two of the three 
patients whose grafts functioned initially required retrans-
plantation because of HAT and CMV hepatitis at 1.4 and 
1.0 months. respectively. Therefore. only one of the six 
livers transplanted from the CNHBD population func-
tioned for a prolonged period of time. 
In the CNHBD, results with respect to the kidneys were 
very similar to the UNHBD. Twenty-one kidneys were 
transplanted and 76% of these experienced ATN. The 
I-year patient and graft survival rates were 94<;;; and 79%. 
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respectively. and with a mean follow-up of 16.5 months. 
70% of the kidneys are still functioning. In contrast to the 
UNHBD group. all eight livers obtained from the CNHBD 
group functioned. Two grafts were lost due to arterial 
complications (HAT and arterial vasculitis) at 1.0 month 
posttransplant. A third graft with stable liver function was 
lost because of a cardiac death 2 months posttransplant. 
This study suggests that the procurement of kidneys from 
both UNHBD and CNHBD leads to acceptable graft 
function despite a high incidence of ATN. The function 01 
liver allografts is adequate in the CNHBD but suboptimal 
in the UNHBD. with a high rate of PNF. In addition. OUI 
NHBD liver series shows a 21% incidence of vascul:lI 
complications. with all patients requiring retransplantatiol1. 
In conclusion. the results of this small series of NHBD 
suggest that viable organs can be procured. In our current 
practice. kidneys from NHBD are utilized for patients 
awaiting transplantation: livers from CNHBD may be used 
for patients awaiting transplantation, while livers from 
UNHBD may be considered only in highly selected cases. 
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